Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients
It may not always be necessary to subject heart transplant patients to one biopsy after another.
Radiation in the cath lab: Tracking state-level regulations for cardiologists
Researchers hope these policies can be standardized in the future to help avoid confusion and improve clinician safety.
Wrongful death lawsuit filed after restrained hospital patient dies of cardiac arrest
The family of Gay Sherman Weintz, 55, said she died as a result of 24-hour physical restraint, combined with staff at Middlesex Hospital ignoring signs of a medical crisis. Her son, Chauncey Smith, has filed a wrongful death lawsuit.
Lab owner indicted in $290M COVID fraud scheme pleads not guilty
Mahmood Sami Khan, 36, has been charged on five counts of wire fraud and money laundering in connection with the conspiracy. If convicted, he could spend the rest of his life behind bars.
PFA market heats up as medtech companies announce new investments
While Kardium raised $250 million in an oversubscribed funding round, Field Medical raised $35 million. Both companies are focused on designing and developing new pulsed field ablation technologies to help treat challenging arrhythmias.

North Dakota has the best health infrastructure during the COVID-19 pandemic

WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.

Heart transplants provide value for patients with AL, ATTR cardiac amyloidosis

With the disease becoming more and more common in the United States, researchers have been hard at work determining the best possible treatment options.

‘Do-not-resuscitate’ orders for COVID-19 patients?

New findings highlight why a blanket “do-not-resuscitate” order for COVID-19 patients is not needed.

Selatogrel provides heart attack patients with a lightning-fast antiplatelet response

A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.

Stroke rates are low among COVID-19 patients—but when they occur, the risk of death is substantial

The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020.

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.

Biopharma may not come out on top from COVID-19 pandemic

While emerging conventional wisdom may state biopharmaceutical companies could see a boon as a result of the COVID-19 pandemic thanks to new treatment and vaccine opportunities, the sector may not come out on top.

New drug combination could lead to the return of an old diabetes treatment

Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.

Clinical

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients

Radiation in the cath lab: Tracking state-level regulations for cardiologists

Wrongful death lawsuit filed after restrained hospital patient dies of cardiac arrest

Lab owner indicted in $290M COVID fraud scheme pleads not guilty

PFA market heats up as medtech companies announce new investments